neurology
Neurodegenerative disorders

Low dose aspirin does not prevent dementia or cognitive decline: ASPREE trial

Taking a low-dose aspirin once a day does not reduce the risk of dementia, MCI, nor does it slow the rate of cognitive decline in elderly people, according to findings from a major Australian-led trial. Published in Neurology the results of the Aspirin in Reducing Events in the Elderly (ASPREE) randomised controlled trial found no ...

Already a member?

Login to keep reading.


OR
© 2021 the limbic